Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans

Suicidal Ideation Clinical Trial

Official title:

Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04896151
• Other study ID #: 2020B0414
• Status: Completed
• Phase: N/A
• Start date: May 15, 2021
• Est. completion date: February 14, 2023

Study information

• Verified date: October 2023
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the current project are is examine the incremental predictive utility of the MMPI-2-RF-EX validity scales in detecting simulated underreporting of suicide risk on the MMPI-2-RF-EX and other self-report measures of suicide risk in 150 military Veterans experiencing past-month death or suicidal ideation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: February 14, 2023
• Est. primary completion date: February 14, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older

• US military veteran

• death or suicidal ideation/suicide attempt within the past month

Exclusion Criteria:

• non-Veteran status

• acute intoxication or active psychosis precluding provision of informed consent

• an inability to communicate and comprehend English

• residence outside the United States

• lack of past-month death/suicide ideation or attempt

• younger than 18 years of age

Related Conditions & MeSH terms

• Suicidal
• Suicidal Ideation
• Suicide

Intervention

Diagnostic Test:
• Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental
The MMPI-2-RF-EX is a broadband, self-report measure of personality and psychopathology was developed for research purposes in order to develop the MMPI-3 (Ben-Porath & Tellegen, 2020), which is comprised of a subset of MMPI-2-RF-EX items.

Locations

Country	Name	City	State
United States	The Ohio State University	Columbus	Ohio

Sponsors (3)

Lead Sponsor	Collaborator
Ohio State University	Rutgers University, University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Short Grit Scale	The Short Grit Scale is an 8-item measure of trait-level perseverance and passion for long-term goals. Possible scores range from 5 to 40, with higher scores indicting higher levels of grit.	Baseline
Other	MMPI Posttest Inquiry (PTI)	The PTI assesses participants' compliance with condition-specific instructions for completing the MMPI and was adapted for the proposed research	Baseline
Other	PTSD Checklist for DSM-5 (PCL-5) PTSD Checklist for DSM-5	The PCL-5 is a self-report measure assessing the severity of 20 PTSD symptoms. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.	Baseline
Primary	MMPI-2-RF-EX Suicidal/Death Ideation scale	The MMPI-2-RF-EX Suicidal/Death Ideation scale is a self-report measure of current suicide risk contained within the instrument. T scores range from 45 to 100, with higher scores indicative of greater suicide risk.	Baseline
Primary	Beck Scale for Suicide Ideation (BSS)	The BSS is a 21-item measure of past-week suicide ideation and desire for death. Responses to items are scored on a 3-point Likert scale (range of 0- 2). Scores range from 0 to 42, with higher scores indicating greater suicide risk.	Baseline
Secondary	Suicide Cognitions Scale (SCS)	The SCS is an 18-item survey measuring suicide-related thoughts and beliefs, unclouding hopelessness, perceived burdensomeness, entrapment, and unbearability. Respondents rate their agreement with each statement on a 5-point Likert scale. Scores range from 18-90, with higher scores indicating more severe suicide risk.	Baseline